Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Current Filters

Recipients:
Volunteering Matters
University of St Andrews
Currency:
GBP
Amounts:
£0 - £500

Filter By

Recipient Region
Recipient District
Award Year
Funding Organizations

Results

Understanding the Role of VPS35 in the Intracellular Movement of Alpha-Synuclein in Neuronal Cells 31 May 2018

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease affecting 10 million people worldwide. A key protein linked to the aetiology of the disorder is alpha-synuclein for which misfolding is linked to the pathogenesis. Importantly alpha-synuclein misfolding can be passed from cell-to-cell by mechanisms which are poorly understood. One proposed mode of transfer is via exosomes, small extracellular vesicles that are released from cells when multi-vesicular endosomes fuse with the plasma membrane. Trafficking in the endosome system therefore has potential to modulate exosome production and affect the transfer of misfolded alpha-synuclein. One gene implicated in late-onset familial PD is vacuolar protein sorting-35 (VPS35). VPS35 is a component of the retromer complex which is a coat protein involved in retrograde trafficking from endosome to the Golgi apparatus. It has the potential to modulate multi-vesicular body (MVB) formation/biogenesis and thereby influence the quantity of exosome-associated alpha-synuclein released from neuronal cells. Our hypothesis is that knockdown of VPS35 will modulate MVB/exosome biogenesis, augmenting the release of exosome-associated alpha-synuclein from cells. We suggest exosomes from VPS35 knockdown cells will be more potent in transfer of alpha-synuclein between cells. This will be observed by using immunoelectron microscopy, Nanocount technology, and immunofluorescence.

Amount: £0
Funder: The Wellcome Trust
Recipient: University of St Andrews